1 / 9

Dr. David Greene Arizona Stem Cell Therapy to Treat Parkinson's Disease

A neurological condition called Parkinson's disease is characterized by increasingly severe pain. It affects about 1% of seniors 60 years or older in industrialized nations. Reliable Source Experts like Dr. David Greene Arizona believe that inherited and environmental factors may be involved, even if the exact cause of the condition remains unknown. Dopamine levels decrease due to Parkinson's disease-related neuronal death in particular brain areas. Dopamine is a neurotransmitter. Brain cells emit dopamine to communicate with other nearby cells.

drdavidgreenearizona
Download Presentation

Dr. David Greene Arizona Stem Cell Therapy to Treat Parkinson's Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DR. DAVID GREENE ARIZONA Stem Cell Therapy to Treat Parkinson's Disease A neurological condition called Parkinson's disease is characterized by increasingly severe pain. It affects about 1% of seniors 60 years or older in industrialized nations. Reliable Source Experts like Dr. David Greene Arizona believe that inherited and environmental factors may be involved, even if the exact cause of the condition remains unknown. Dopamine levels decrease due to Parkinson's disease-related neuronal death in particular brain areas. Dopamine is a neurotransmitter. DR. DAVID GREENE ARIZONA | STEM CELL THERAPY TO TREAT PARKINSON'S DISEASE

  2. WHEN DOPAMINE ACTIVITY IS DECREASED, THESE PARKINSON'S SYMPTOMS ARE AMONG THEM: Tremors Slowness Rigidity Gait Disturbance There is no recognized treatment for Parkinson's disease. However, experts like Dr. David Greene Arizona have recently investigated stem cell therapy to offer new therapeutic options. Keep reading for more information on current and upcoming developments in stem cell therapy for Parkinson's disease. Multiple approaches to using stem cells to treat Parkinson's disease are being researched.

  3. WHEN DOPAMINE ACTIVITY IS DECREASED, THESE PARKINSON'S SYMPTOMS ARE AMONG THEM: The goal is to directly inject stem cells into the damaged areas of the brain, where they will mature into brain cells. The condition's symptoms should be lessened by these new brain cells' regulation of dopamine levels. It's essential to remember that researchers do not believe this would be a treatment for Parkinson's, only a possible cure.

  4. WHAT HAVE CLINICAL TRIALS FOUND? Before developing the technique for creating iPSCs, the only stem cell therapy for Parkinson's disease involved embryonic stem cells. However, this created moral and practical issues, which made the research process more challenging. Since iPSCs were made available, stem cells have been used in clinical trials for disorders involving brain damage, with largely unreliable results.

  5. WHAT HAVE CLINICAL TRIALS FOUND? Trials have shown improvement in both movement problems and non-motor symptoms, such as bladder control. There are various challenges in the stem cell's place of origin. Using stem cells is comparable to transplanting an organ. For instance, if the iPSCs were taken from a donor, you might need to take immunosuppressant drugs to prevent your body from rejecting them. iPSCs created from your cells might be less likely to be rejected by your body.

  6. WHAT WILL THE FURTHER GENERATION OF CLINICAL TRIALS FOCUS ON? There are several Parkinson's disease symptoms. As a result, the Movement Disorder Society's MDS-UPDRS, an updated version of the Unified Parkinson's Disease Rating Scale (UPDRS), is widely used to assess them. Today's clinical trials aim to significantly increase individuals with Parkinson's disease's UPDRS or MDS- UPDRS scores. New delivery methods, such as intravenous or topical therapies, are being investigated in certain trials. Others are attempting to determine the maximum number of safe, effective doses.

  7. WHAT WILL THE FURTHER GENERATION OF CLINICAL TRIALS FOCUS ON? The general safety of using innovative medical devices in stem cell therapy is also evaluated in other investigations. This area is still being researched. However, future research by specialists like Dr. David Greene Arizona will help to identify the most secure and effective approach to Parkinson's stem cell therapy.

  8. TAKEAWAY The objective of stem cell therapy for Parkinson's disease is to replace harmed brain cells with fresh, undifferentiated stem cells. As they mature into brain cells, these stem cells may then control your dopamine dramatically lessen several symptoms, according to doctors. This medication is still being tested in the clinical setting. However, many proposed research are either currently underway or are actively seeking participants. The outcomes of these trials will determine how quickly stem cell therapy as a treatment for Parkinson's disease might become widely available. levels. Parkinson's This can disease

  9. THANK YOU! The regenerative medicine therapies we offer at R3 Stem Cell help people live healthier, pain-free lives. Our Centers of Excellence are staffed with experienced and compassionate providers dedicated to helping our patients reach their health goals. Address: 1112 Goodlette Road North, Suite 203 Ph.No.: 239-263-8444 www.r3stemcell.com

More Related